Skip to main content
Premium Trial:

Request an Annual Quote

Affy Names Four New Service Firms to Embolden Market Stance in Japan

NEW YORK, May 8 - Affymetrix Japan, a wholly owned subsidiary of Affymetrix, has chosen four companies to be authorized service providers for its customers in Japan:


Beginning June 1, BioMatrix Laboratories, Kurabo Industries, Mitsubishi Chemical Safety Institute, and Takara Bio will offer customer services that include scanning and analyzing data from Affy GeneChips, and providing technical support for the instruments.


These partnerships "will make GeneChip technology more accessible to its academic and industrial customers, and help forge closer working relationships with the broader Japanese scientific community," said Sadashi Suzuki, general manager of Tokyo-based Affymetrix Japan.


There are currently more that 100 GeneChip systems in Japan, according to Suzuki.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.